References
- Fischhoff B. Qual Saf Health Care. Quality & Safety in Health Care. 2003;12(4):304–312.
- Giroux ME, Patricia I. Coburn Hindsight Bias and Law. Zeitschriftfür Psychologie. 2016;224(3):190–203.
- Witherspoon J F. Nonobviousness: the ultimate condition of patentability; papers compiled in commemoration of the silver anniversary of 35 USC 103. Burea of National Affairs:Washington (DC).1979
- Stephen G, Philippe JC, Signore. A Comparative analysis of the inventive step standard in the european and japanese patent offices from a us perspective, IPLITIGATOR, Jan./Feb. 2008.
- Graham V John Deere Co., 383 U.S. 1 (1966) [ cited 2019 Nov 13]. Available from: http://supreme.justia.com/cases/federal/us/383/1/
- Calmar, Incorporated, Appellant, v. Cook Chemical Company, Appellee. Colgate-Palmolive Company, Appellant, v. Cook Chemical Company, Appellee, 336 F.2d 110 (8th Cir. 1964). [ Cited 2019 Dec 10]. Available from: http://law.justia.com/cases/federal/appellate-courts/F2/336/110/380175/
- United States v. Adams, 383 U.S. 39 (1966). [ Cited 2020 Jan 15]. Available from: http://www.ca6.uscourts.gov/opinions.pdf/13a0179p-06.pdf
- Stratoflex, Inc. v. Aeroquip Corp. United States Court of Appeals for the Federal Circuit 713 F.2d 1530 (1983). [ Cited 2020 Jan 15]. Available from: https://law.justia.com/cases/federal/appellate-courts/F2/713/1530/149624/
- ACD Hosp Sys v. Montefiore Hosp, 732 F.2d 1572 (U.S. Court of Appeals for the Federal Circuit, 1984) [ cited 2020 Jan 15]. Available from: https://law.justia.com/cases/federal/appellate-courts/F2/732/1572/129424/
- In re Dembiczak, 175 F.3d 994, 999, 50 USPQ2d 1614, 1617 (Fed. Cir. 1999) [ cited 2021 Apr 12]. Available from: https://casetext.com/case/in-re-dembiczak
- KSR Int’l Co. v. Teleflex Inc. 550 U.S. 398 (2007), citing 550 U.S. at 421, 127S. Ct.1727. [ cited 2020 Aug 22] Available from: https://supreme.justia.com/cases/federal/us/550/398/opinion.html
- Mandel GN. Patently Non-Obvious: empirical Demonstration that the Hindsight Bias Renders Patent Decisions Irrational. Ohio State Law Journal. 2006;67:1391–1463.
- Michael L, McGinley V Franklin Sports, 262 F.3d 1339 (U.S. Court of Appeals for the Federal Circuit, 2001). [ cited 2021 Apr 12]. Available from https://casetext.com/case/mcginley-v-franklin-sports-inc-6
- Mandel GN. Patently Non-Obvious Experimental Study on the Hindsight Issue Before the Supreme Court in KSR V. Teleflex, Yale Journal of Law and Technology. 2007;9(1):1–43.
- Mandel GN. Non obviousness-The Shape of Things to Come. Lewis & Clark Law Review. 2008;12(2):324–342.
- Zachary Q. Hindsight Bias in Patent Law: comparing the USPTO and the EPO. Fordham International Law journal. 2014;37(6):1787–1820.
- Bolt A. Combating Hindsight Reconstruction in Patent Prosecution. Emory Law Journal. 2015;64(1137):1137–1173.
- David. T. Altogether obvious: hindsight bias and the evaluation of innovations. Washington: Foster School of Business University of Washington; 2017. Jan 20 1–43
- MPEP Guidelines 37 C.F.R. § 41.50(a) (1). USPTO.gov [internet] United States. [ cited 2020 Feb 19]. Available from: https://www.uspto.gov/web/offices/pac/mpep/s1214.html
- MPEP Guidelines 37 C.F.R. § 41.50(b). USPTO.gov [internet] United States [ cited 2020 Feb 19]. Available from https://www.uspto.gov/web/offices/pac/mpep/s1214.html
- USPTO.gov [internet] United States [ cited 2020 Feb 19] Available from https://www.uspto.gov/patent/laws-and-regulations/america-invents-act-aia/inter-partes-disputes
- Sivakami D, Kulkarni M. Nonobviousness of pharmaceutical inventions: implications for patent prosecution and litigation. Pharm Pat Anal. 2019;8(1):1–17.
- US Food and Drug Administration. Generic Competition and Drug Prices. 2010; [ cited 2019 Mar 3]. Available from http://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDER/ucm129385.htm Accessed 2016 Mar 3.
- Morella AM. inventor; Alpharma Pharmaceuticals LLC, assignee. Sustained release pharmaceutical composition. United States patent US. 1994 Jul 19;5330:766.
- Baichwal AR. inventor; Penwest Pharmaceuticals Co, assignee. Controlled release oxybutynin formulations. United States patent US. 1995 Mar 21;5(399):359.
- Agostinelli JA. inventor; Eastman Kodak Co, assignee. Processes of forming Ag doped conductive crystalline bismuth mixed alkaline earth copper oxide films. United States patent US. 1992 Jan 21;58:2688.
- Artursson P. Epithelial Transport of Drugs in Cell Culture. I: a Model for Studying the Passive Diffusion of Drugs over Intestinal Absorptive (Caco-2) Cells. J Pharm Sci. 1990;79(6):476–482.
- Riley SA, Kim M, Sutcliffe F, et al. Absorption of Polar Drugs Following Caecal Instillation in Healthy Volunteers. Aliment Pharmacol Ther. 1992;6(6):701–706.
- Alza Corporation v. Mylan Laboratories, 464 F.3d 1286 (U.S. Court of Appeals for the Federal Circuit, 2006) [ cited 2020 Feb 20] Available from https://www.casemine.com/judgement/us/5914b4e2add7b0493476f22a
- Banno K. inventor; Otsuka Pharmaceutical Co Ltd, assignee Pharmaceutically useful carbostyril derivatives. United States patent US. 1988;4(734):416.Mar 29
- Banno K. inventor; Otsuka Pharmaceutical Co Ltd, assignee. New carbostyril derivatives, processes for their preparation and containing the same medium. German patent DE. 1979 Aug 11;2(912):105.
- Murasaki M. New Psycho-Neuro Agents. Japanese J. Clinical Psychiatry. 1987;1515(1517):5891–5919.
- Takeda Chem. Indus., Ltd. v. Alphapharm Pty. Ltd., No. 06-1329 (2007). [ cited 2020 Jul 3] Available from http://www.ub.edu/centredepatents/pdf/doc_dilluns_CP/Takeda-vs-Alphapharm_USFedCir-June28-2007_refers%20to%20KSR.pdf/
- KSR Int’l Co. v. Teleflex Inc. 550 U.S. 398 (2007), citing Eisai, 533 F.3d at 1357 KSR, 550 U.S. at 415, 127S. Ct.1727. [ cited 2020 Aug 22] Available from: https://supreme.justia.com/cases/federal/us/550/398/opinion.html
- Otsuka Pharmaceutical Co., Ltd. v. Sandoz, Inc, Nos 11-1126 Fed. Cir. May 7, (2012) [ cited 2020 Aug 22]. Available from https://www.patentdocs.org/2012/05/otsuka-pharmaceutical-co-v-sandoz-inc-fed-cir-2012.html
- Eurand. V, Labs I. Cyclobenzaprine Hydrochloride Extended-Release Capsule Patent Litigation 2012-1280. U.S. Court of Appeals for the Federal Circuit; 2013.
- Commercon A. Practical Semi synthesis and Antimitotic Activity of Docetaxel and Side-Chain Analogues, in Taxane Anticancer Agents. 1994; 233–246. Basic Science and Current Status.
- Ojima I. Syntheses and Structure-Activity Relationships of New Taxoids. In: Georg GI, editor. Taxane Anticancer Agents. Basic Science and Current Status 262. ACS Publicaitions, USA. 1994. p. 262–275.
- William NH, Dana TA, Design R. Pre-Clinical Pharmacology of Drugs for Reversing Multidrug Resistance. Biochem Pharmacol. 1992;43(1):103–107.
- Theodore JL. Relevance of the Chemical Charge of Rhodamine Dyes to Multiple Drug Resistance. Biochem Pharmacol. 1989;38(23):4267–4271.
- Sanofi-Aventis US v. Dr. Reddy’s laboratories, Inc., (2016-2018) [ cited 2020 Aug 30]. Available from https://casetext.com/case/sanofi-aventis-us-llc-v-dr-reddys-labs-inc
- Jain AK. Bupropion SR vs. Placebo for Weight Loss in Obese Patients with Depressive Symptoms. Obes Res. 2002;10(10):1049–1056.
- Nalpropion PV Actavis Labs. FL, 20192018-1221 (U.S. Court of Appeals for the Federal Circuit, 2019). ( cited 2020 Aug 30). Available from https://law.justia.com/cases/federal/appellate-courts/cafc/18-1221/18-1221-2019-08-15.html
- Markwood JH. inventor; Hercules Powder Co, assignee; Uniaxial orientation of polypropylene film. United States patent US. 1965 Aug 26;3(214):503.
- SSmith J, inventor; EI Du Pont de Nemours and Co, assignee. Highly oriented shaped tetrafluoroethylene article and process for producing the same. United States patent US 2,776,465. 1957 Jan 08
- Titterton WE. inventor; Resistoflex Corp, assignee; Blow molding of polytetrafluoroethylene. United States patent US. 1961 May 16;2(983):961.
- Eugene CD. Effect of strain rate on the viscoelastic properties of high polymeric fibrous materials. J Appl Polym Sci. 1964.
- Gore WL Associates Inc. v. Garlics Inc., 842 F.2d 1275 (U. S. Court of Appeals, Federal Circuit, 1988). [ cited 2020 Aug 29] Available from https://casetext.com/case/wl-gore-associates-inc-v-garlock-inc-2